{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "NOK", "esgPopulated": false, "market": "no_market", "longName": "Ultimovacs ASA", "marketState": "REGULAR", "regularMarketPrice": 127.8, "messageBoardId": "finmb_241624822", "exchange": "OSL", "shortName": "ULTIMOVACS", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Oslo", "regularMarketChangePercent": -0.15624762, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 69.3, "fiftyTwoWeekLowChangePercent": 1.1846155, "fiftyTwoWeekRange": "58.5 - 142.6", "fiftyTwoWeekHighChange": -14.800003, "fiftyTwoWeekHighChangePercent": -0.10378683, "fiftyTwoWeekLow": 58.5, "fiftyTwoWeekHigh": 142.6, "earningsTimestamp": 1683720000, "earningsTimestampStart": 1683720000, "earningsTimestampEnd": 1683720000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.97, "epsForward": 7.62, "epsCurrentYear": -4.15, "firstTradeDateMilliseconds": 1559545200000, "priceHint": 2, "regularMarketChange": -0.19999695, "regularMarketTime": 1684140594, "regularMarketDayHigh": 128.6, "regularMarketDayRange": "126.8 - 128.6", "regularMarketDayLow": 126.8, "regularMarketVolume": 12258, "regularMarketPreviousClose": 128.0, "bid": 127.8, "ask": 128.2, "fullExchangeName": "Oslo", "financialCurrency": "NOK", "regularMarketOpen": 128.6, "averageDailyVolume3Month": 39263, "averageDailyVolume10Day": 34823, "priceEpsCurrentYear": -30.795181, "sharesOutstanding": 34396500, "bookValue": 13.064, "fiftyDayAverage": 118.824, "fiftyDayAverageChange": 8.976006, "fiftyDayAverageChangePercent": 0.07554034, "twoHundredDayAverage": 98.362, "twoHundredDayAverageChange": 29.438004, "twoHundredDayAverageChangePercent": 0.29928228, "marketCap": 4450813952, "forwardPE": 16.771654, "priceToBook": 9.782609, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "ULTI.OL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Ullernchauss\u00e9en 64", "city": "Oslo", "zip": "0379", "country": "Norway", "phone": "47 41 38 00 80", "website": "https://ultimovacs.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.", "fullTimeEmployees": 22, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carlos  de Sousa", "age": 64, "title": "Chief Exec. Officer", "yearBorn": 1958, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hans Vassg\u00e5rd Eid", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ingunn Hagen Westgaard Ph.D.", "title": "Head of Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Audun  Tornes", "title": "Chief Technology Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anne H. Worsoe", "title": "Head of Investor Relations & ESG", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jens Egil Torbjorn Bjorheim M.D., Ph.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Oivind  Foss Ph.D.", "title": "Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Gudrun  Troite Ph.D.", "title": "Head of Project Coordination", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Antonius  Berkien", "age": 54, "title": "Chief Bus. Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Orla  Mc Callion", "title": "Head of Regulatory Affairs & QA", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}